Evaluation of Retinal Layer Thickness Parameters as Biomarkers in a Real-World Multiple Sclerosis Cohort.

Natascha SchurzLydia SariaslaniPatrick AltmannFritz LeutmezerChristoph MitschBerthold PempPaulus RommerTobias ZrzavyThomas Berger Gabriel Bsteh

Published in: Eye and brain (2021)

Cross-sectional and longitudinal measurement of GCIPL and pRNFL thinning is reliable as a biomarker of disability worsening in a real-world setting. Change of INL thickness is a promising marker of relapse, i.e. inflammatory activity.

Keyphrases

multiple sclerosis
optical coherence tomography
cross sectional
diabetic retinopathy
white matter
oxidative stress
optic nerve